B7-H1 expressed by activated CD8 T cells is essential for their survival

Journal of Immunology

Volumn 187, Issue 11, 2011, Pages 5606-5614

  Pulko, Vesna ^a   Harris, Kimberley J ^a   Liu, Xin ^a   Gibbons, Rachel M ^a   Harrington, Susan M ^a   Krco, Christopher J ^a   Kwon, Eugene D ^a   Dong, Haidong ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CALCIUM; FAS LIGAND; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN BCL XL; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD274; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 82755186778     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003976     Document Type: Article

References (35)

1. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
2. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
3. Zang, X., and J. P. Allison. 2007. The B7 family and cancer therapy: costimulation and coinhibition. Clin. Cancer Res. 13: 5271-5279. (Pubitemid 47510350)
4. Dong, H., and L. Chen. 2003. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 81: 281-287. (Pubitemid 36718324)
5. Flies, D. B., and L. Chen. 2007. The new B7s: playing a pivotal role in tumor immunity. J. Immunother. 30: 251-260. (Pubitemid 46586641)
6. Zha, Y., C. Blank, and T. F. Gajewski. 2004. Negative regulation of T-cell function by PD-1. Crit. Rev. Immunol. 24: 229-237. (Pubitemid 40052425)
7. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704. (Pubitemid 351600389)
8. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545. (Pubitemid 35291652)
9. Dong, H., S. E. Strome, E. L. Matteson, K. G. Moder, D. B. Flies, G. Zhu, H. Tamura, C. L. Driscoll, and L. Chen. 2003. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 111: 363-370. (Pubitemid 36182213)
10. Rowe, J. H., T. M. Johanns, J. M. Ertelt, and S. S. Way. 2008. PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes. J. Immunol. 180: 7553-7557.
11. Seo, S. K., H. Y. Jeong, S. G. Park, S. W. Lee, I. W. Choi, L. Chen, and I. Choi. 2008. Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection. Immunology 123: 90-99. (Pubitemid 350256000)
12. Kanai, T., T. Totsuka, K. Uraushihara, S. Makita, T. Nakamura, K. Koganei, T. Fukushima, H. Akiba, H. Yagita, K. Okumura, et al. 2003. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171: 4156-4163. (Pubitemid 37238692)
13. Lee, S. J., H. O'Donnell, and S. J. McSorley. 2010. B7-H1 (programmed cell death ligand 1) is required for the development of multifunctional Th1 cells and immunity to primary, but not secondary, Salmonella infection. J. Immunol. 185: 2442-2449.
14. Dong, H., G. Zhu, K. Tamada, D. B. Flies, J. M. van Deursen, and L. Chen. 2004. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 20: 327-336. (Pubitemid 38388234)
15. Ahonen, C. L., C. L. Doxsee, S. M. McGurran, T. R. Riter, W. F. Wade, R. J. Barth, J. P. Vasilakos, R. J. Noelle, and R. M. Kedl. 2004. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J. Exp. Med. 199: 775-784. (Pubitemid 38375197)
16. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78. (Pubitemid 37324571)
17. Lichtenfels, R., W. E. Biddison, H. Schulz, A. B. Vogt, and R. Martin. 1994. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods 172: 227-239. (Pubitemid 24232713)
18. Pulko, V., X. Liu, C. J. Krco, K. J. Harris, X. Frigola, E. D. Kwon, and H. Dong. 2009. TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination. J. Immunol. 183: 3634-3641.
19. Pilon-Thomas, S., A. Mackay, N. Vohra, and J. J. Mulé. 2010. Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma. J. Immunol. 184: 3442-3449.
20. Hirano, F., K. Kaneko, H. Tamura, H. Dong, S. Wang, M. Ichikawa, C. Rietz, D. B. Flies, J. S. Lau, G. Zhu, et al. 2005. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res. 65: 1089-1096. (Pubitemid 40216472)
21. Jayaraman, S. 2005. Flow cytometric determination of mitochondrial membrane potential changes during apoptosis of T lymphocytic and pancreatic beta cell lines: comparison of tetramethylrhodamineethylester (TMRE), chloromethyl-Xrosamine (H2-CMX-Ros) and MitoTracker Red 580 (MTR580). J. Immunol. Methods 306: 68-79. (Pubitemid 41742215)
22. Latchman, Y. E., S. C. Liang, Y. Wu, T. Chernova, R. A. Sobel, M. Klemm, V. K. Kuchroo, G. J. Freeman, and A. H. Sharpe. 2004. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA 101: 10691-10696. (Pubitemid 38955804)
23. Seo, S. K., H. M. Seo, H. Y. Jeong, I. W. Choi, Y. M. Park, H. Yagita, L. Chen, and I. H. Choi. 2006. Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response. Immunol. Lett. 102: 222-228. (Pubitemid 43053091)
24. Su, M. W., S. Pyarajan, J. H. Chang, C. L. Yu, Y. J. Jin, Y. D. Stierhof, P. Walden, and S. J. Burakoff. 2004. Fratricide of CD8+ cytotoxic T lymphocytes is dependent on cellular activation and perforin-mediated killing. Eur. J. Immunol. 34: 2459-2470. (Pubitemid 39302803)
25. Chai, J. G., I. Bartok, D. Scott, J. Dyson, and R. Lechler. 1998. T:T antigen presentation by activated murine CD8+ T cells induces anergy and apoptosis. J. Immunol. 160: 3655-3665. (Pubitemid 28176065)
26. Hanon, E., J. C. Stinchcombe, M. Saito, B. E. Asquith, G. P. Taylor, Y. Tanaka, J. N. Weber, G. M. Griffiths, and C. R. Bangham. 2000. Fratricide among CD8 (+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 13: 657-664.
27. Vahlenkamp, T. W., M. E. Bull, J. L. Dow, E. W. Collisson, B. J. Winslow, A. P. Phadke, W. A. Tompkins, and M. B. Tompkins. 2004. B7+CTLA4+ T cells engage in T-T cell interactions that mediate apoptosis: a model for lentivirusinduced T cell depletion. Vet. Immunol. Immunopathol. 98: 203-214. (Pubitemid 38317033)
28. Boise, L. H., A. J. Minn, P. J. Noel, C. H. June, M. A. Accavitti, T. Lindsten, and C. B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87-98.
29. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687. (Pubitemid 28119121)
30. Farley, N., G. Pedraza-Alva, D. Serrano-Gomez, V. Nagaleekar, A. Aronshtam, T. Krahl, T. Thornton, and M. Rincón. 2006. p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells. Mol. Cell. Biol. 26: 2118-2129. (Pubitemid 43346915)
31. Chetoui, N., M. Boisvert, S. Gendron, and F. Aoudjit. 2010. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway. Immunology 130: 418-426.
32. Goldberg, M. V., C. H. Maris, E. L. Hipkiss, A. S. Flies, L. Zhen, R. M. Tuder, J. F. Grosso, T. J. Harris, D. Getnet, K. A. Whartenby, et al. 2007. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood 110: 186-192. (Pubitemid 47026834)
33. Ortler, S., C. Leder, M. Mittelbronn, A. L. Zozulya, P. A. Knolle, L. Chen, A. Kroner, and H. Wiendl. 2008. B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. Eur. J. Immunol. 38: 1734-1744.
34. Subudhi, S. K., P. Zhou, L. M. Yerian, R. K. Chin, J. C. Lo, R. A. Anders, Y. Sun, L. Chen, Y. Wang, M. L. Alegre, and Y. X. Fu. 2004. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113: 694-700. (Pubitemid 38544162)
35. Wahl, C., P. Bochtler, L. Chen, R. Schirmbeck, and J. Reimann. 2008. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses. Gastroenterology 135: 980-988.